Analysis of FGFR3 gene mutations in multiple myeloma patients with t(4;14)
Open Access
- 1 August 2001
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 114 (2) , 362-364
- https://doi.org/10.1046/j.1365-2141.2001.02957.x
Abstract
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.Keywords
This publication has 12 references indexed in Scilit:
- Frequent activating mutations of FGFR3 in human bladder and cervix carcinomasNature Genetics, 1999
- Detection of t(4;14)(p16.3;q32) Chromosomal Translocation in Multiple Myeloma by Double-Color Fluorescent In Situ HybridizationBlood, 1999
- FGFR3 Gene Mutations Associated With Human Skeletal Disorders Occur Rarely in Multiple MyelomaBlood, 1998
- A Novel Chromosomal Translocation t(4; 14)(p16.3; q32) in Multiple Myeloma Involves the Fibroblast Growth-Factor Receptor 3 GeneBlood, 1997
- Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3Nature Genetics, 1997
- FGFR activation in skeletal disorders: Too much of a good thingTrends in Genetics, 1997
- Genomic Organization of the Human Fibroblast Growth Factor Receptor 3 (FGFR3) Gene and Comparative Sequence Analysis with the MouseFgfr3GeneGenomics, 1997
- Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasiaNature Genetics, 1996
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975